Skip to main content
. 2023 Apr 16;11(4):852. doi: 10.3390/vaccines11040852

Table 4.

No. and type of intramuscularly delivered vaccines as first doses and no. of angioedema attacks following the vaccination (≤72 h).

Total BNT162b2 mRNA-1273 ChAdOx1-S Ad26.COV2.S
No. of vaccination doses (%) 202 (100%) 174 (86.1%) 16 (7.9%) 11 (5.5%) 1 (0.5%)
No. of angioedema attacks (≤72 h) (%) 15 (100%) 12 (80%) 1 (6.7%) 1 (6.7%) 1 (6.7%)